245 related articles for article (PubMed ID: 27178440)
1. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
Liu W; Rodgers GP
Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
[TBL] [Abstract][Full Text] [Related]
2. Olfactomedin-4 in digestive diseases: A mini-review.
Wang XY; Chen SH; Zhang YN; Xu CF
World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
[TBL] [Abstract][Full Text] [Related]
3. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
[TBL] [Abstract][Full Text] [Related]
4. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.
Liu W; Yan M; Liu Y; Wang R; Li C; Deng C; Singh A; Coleman WG; Rodgers GP
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11056-61. PubMed ID: 20534456
[TBL] [Abstract][Full Text] [Related]
5. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor.
Chin KL; Aerbajinai W; Zhu J; Drew L; Chen L; Liu W; Rodgers GP
Br J Haematol; 2008 Nov; 143(3):421-32. PubMed ID: 18764868
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer.
Ma H; Tian T; Liang S; Liu X; Shen H; Xia M; Liu X; Zhang W; Wang L; Chen S; Yu L
Oncotarget; 2016 Mar; 7(9):10594-605. PubMed ID: 26871282
[TBL] [Abstract][Full Text] [Related]
7. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
9. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.
Yu L; Wang L; Chen S
Neoplasma; 2011; 58(1):9-13. PubMed ID: 21067260
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
[TBL] [Abstract][Full Text] [Related]
11. Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.
Li H; Liu W; Chen W; Zhu J; Deng CX; Rodgers GP
Sci Rep; 2015 Nov; 5():16974. PubMed ID: 26581960
[TBL] [Abstract][Full Text] [Related]
12. Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades.
Klaas M; Mäemets-Allas K; Heinmäe E; Lagus H; Arak T; Eller M; Kingo K; Kankuri E; Jaks V
Cell Mol Life Sci; 2022 Feb; 79(3):157. PubMed ID: 35218417
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer.
Li H; Rodriguez-Canales J; Liu W; Zhu J; Hanson JC; Pack S; Zhuang Z; Emmert-Buck MR; Rodgers GP
Am J Pathol; 2013 Oct; 183(4):1329-38. PubMed ID: 24070418
[TBL] [Abstract][Full Text] [Related]
14. Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC.
Li H; Chaitankar V; Zhu J; Chin K; Liu W; Pirooznia M; Rodgers GP
Sci Rep; 2020 Dec; 10(1):21924. PubMed ID: 33318499
[TBL] [Abstract][Full Text] [Related]
15. Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis.
Grover PK; Hardingham JE; Cummins AG
Cancer Metastasis Rev; 2010 Dec; 29(4):761-75. PubMed ID: 20878207
[TBL] [Abstract][Full Text] [Related]
16. Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.
Guette C; Valo I; Vétillard A; Coqueret O
Proteomics Clin Appl; 2015 Feb; 9(1-2):58-63. PubMed ID: 25400027
[TBL] [Abstract][Full Text] [Related]
17. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A
J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502
[TBL] [Abstract][Full Text] [Related]
18. Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice.
Liu W; Yan M; Liu Y; McLeish KR; Coleman WG; Rodgers GP
J Immunol; 2012 Sep; 189(5):2460-7. PubMed ID: 22844115
[TBL] [Abstract][Full Text] [Related]
19. Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD.
Gersemann M; Becker S; Nuding S; Antoni L; Ott G; Fritz P; Oue N; Yasui W; Wehkamp J; Stange EF
J Crohns Colitis; 2012 May; 6(4):425-34. PubMed ID: 22398066
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
